Evaluation of Robotic Exoskeletons Therapy for Gait Rehabilitation in Patients With Incomplete Spinal Cord Injury.
About this trial
This trial is recruiting individuals with incomplete spinal cord injuries to test the use of a robotic exoskeleton (Exo-H2). The main goal is to see if this device, which is temporarily attached to the body from the waist down, can improve walking after injury. Participants will receive either: 1) walking training with the exoskeleton; or 2) traditional walking training without the exoskeleton. Final walking tests will be made 2 months after the end of the study.
Included participants
Traumatic
Non-traumatic
What’s involved
Type
Details
The participant will receive either 1) walking training with the Exo-H2 exoskeleton or 2) traditional walking training without the exoskeleton. Final walking tests 2 months after the end of the study at the study center.
Potential benefits
Main benefits
Standing/walking/mobility
Additional benefits
Arm/hand function
General health
Spasticity
Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.
Wings for Life supports SCITrialsFinder
Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn more- Trial recruitment status
- Ended
- Trial start date
- 1 Jan 2016
- Organisation
- Hospital Nacional de Parapléjicos de Toledo
- Trial recruitment status
- Ended
- Trial start date
- 1 Jan 2016
- Organisation
- Hospital Nacional de Parapléjicos de Toledo
About this trial
Included participants
What’s involved
Potential benefits
Wings for Life supports SCITrialsFinder
Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn more